Company page
Biogend Therapeutics Co., Ltd.
Biogend Therapeutics Co., Ltd. is a public company traded under the ticker 6733 on the Taiwan market. The company has a market capitalization of approximately NT$109.95 million. Biogend focuses on developing innovative therapeutic solutions in the biotechnology sector.
- Ticker
- 6733
- Market cap
- $109.9M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services